Status:
COMPLETED
SmartTouch Catheter for Left Anterior Line - SmarT Line Study
Lead Sponsor:
LMU Klinikum
Conditions:
Persistent Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This prospective, randomized study will investigate, if information of the catheter force during ablation of a left anterior line does reduce total RF application time by prevention of ineffective les...
Detailed Description
Catheter ablation has emerged as a realistic therapeutic option for symptomatic atrial fibrillation (AF). The three main techniques described for ablation of persistent AF include pulmonary vein (PV)...
Eligibility Criteria
Inclusion
- Patients with symptomatic atrial fibrillation and additional substrate modification or perimitral flutter
- Patients with persistent atrial fibrillation
- Patients with perimitral flutter
- Patients with recurrence after a circumferential PV isolation procedure
- Patients with paroxysmal atrial fibrillation and AF episodes lasting \> 7 days
- Patients (\>18 und \<80 Jahre)
Exclusion
- moderate to severe valvular heart disease,
- congenital heart disease
- reduced left ventricular function (ejection fraction \<35%)
- any reversible cause for atrial fibrillation (e.g. hyperthyroidism)
- intracardiac thrombi documented by transesophageal echocardiography
- myocardial infarction within 3 months, cardiac surgery in the previous three months
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02217657
Start Date
August 1 2013
End Date
December 1 2016
Last Update
February 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Munich University Clinic, Campus Großhadern
Munich, Bavaria, Germany, 81377